Search - tctmd.com

Displaying 741 - 760 of 962

Sort: Relevancy | Date

News Daily News

Aortic Regurgitation Risk, Consequences Vary Between First-Generation TAVR Devices

Caitlin E. Cox

August 07, 2014

News Daily News

Local Anesthesia ‘Preferable’ Over General for Transfemoral TAVR

Yael L. Maxwell

July 24, 2014

News Industry News

Boston Scientific Receives CE Mark For The New 25 mm Lotus™ Valve System

July 14, 2014

News Daily News

VIVID Registry: Benefit of Valve-in-Valve TAVR Depends on Size, Status of Failed Surgical Bioprosthesis

July 10, 2014

News Daily News

MitraClip给高风险和不能手术的二尖瓣反流患者带来益处

July 10, 2014

News Daily News

MitraClip Benefits High-, Prohibitive-Risk Patients with Mitral Regurgitation

July 10, 2014

News Daily News

MitraClip Beneficia a Pacientes de Riesgo Alto y Prohibitivo con Regurgitacion Mitral

July 10, 2014

News Daily News

Some Long-term Drop-Off in Favorable Outcomes Seen in Early CoreValve Series

July 03, 2014

News Daily News

Transesophageal Echo Leads to Wrong CoreValve Sizing in Nearly Half of Patients

L.A. McKeown

June 24, 2014

News Daily News

La Eco Transesofágica Provoca el Dimensionamiento Erróneo de CoreValve en Casi la Mitad de los Pacientes

L.A. McKeown

June 24, 2014

News Industry News

CardiAQ™ Valve Technologies files US Lawsuit against Neovasc

June 06, 2014

News Industry News

Boston Scientific Initiates the RESPOND Post Market Registry Evaluating Clinical Outcomes in Patients Implanted With Lotus™ Valve System

June 04, 2014

News Daily News

Preprocedural Patient Factors Useful for Predicting Poor Outcome Following TAVR

L.A. McKeown

June 03, 2014

News Conference News EuroPCR 2014

Studies Document Initial Steps Toward Percutaneous Mitral Valve Replacement

Caitlin E. Cox

May 23, 2014

News Conference News EuroPCR 2014

New Iteration of Sapien Device Associated with Low Rates of Early Mortality, Stroke

L.A. McKeown

May 23, 2014

News Conference News EuroPCR 2014

UK Registry Finds Long-Term Survival After TAVR Depends on Patient Characteristics

Caitlin E. Cox

May 22, 2014

News Conference News EuroPCR 2014

Early Data Show Novel Catheter-Implanted Device Benefits Patients with Left Heart Failure

Caitlin E. Cox

May 22, 2014

News Industry News

DIRECT FLOW MEDICAL® TRANSCATHETER AORTIC VALVE SYSTEM DEMONSTRATES EXCELLENT 12 MONTH OUTCOMES IN DISCOVER CE MARK TRIAL

May 22, 2014

News Industry News

DIRECT FLOW MEDICAL, INC. ANNOUNCES IDE APPROVAL FOR U.S. PIVOTAL TRIAL

May 21, 2014

News Industry News

Boston Scientific Lotus™ Valve System Demonstrates Strong Performance And Safety Profile At Six Months

May 21, 2014

Advertisement

Aortic Regurgitation Risk, Consequences Vary Between First-Generation TAVR Devices

Local Anesthesia ‘Preferable’ Over General for Transfemoral TAVR

Boston Scientific Receives CE Mark For The New 25 mm Lotus™ Valve System

VIVID Registry: Benefit of Valve-in-Valve TAVR Depends on Size, Status of Failed Surgical Bioprosthesis

MitraClip给高风险和不能手术的二尖瓣反流患者带来益处

MitraClip Benefits High-, Prohibitive-Risk Patients with Mitral Regurgitation

MitraClip Beneficia a Pacientes de Riesgo Alto y Prohibitivo con Regurgitacion Mitral

Some Long-term Drop-Off in Favorable Outcomes Seen in Early CoreValve Series

Transesophageal Echo Leads to Wrong CoreValve Sizing in Nearly Half of Patients

La Eco Transesofágica Provoca el Dimensionamiento Erróneo de CoreValve en Casi la Mitad de los Pacientes

CardiAQ™ Valve Technologies files US Lawsuit against Neovasc

Boston Scientific Initiates the RESPOND Post Market Registry Evaluating Clinical Outcomes in Patients Implanted With Lotus™ Valve System

Preprocedural Patient Factors Useful for Predicting Poor Outcome Following TAVR

Studies Document Initial Steps Toward Percutaneous Mitral Valve Replacement

New Iteration of Sapien Device Associated with Low Rates of Early Mortality, Stroke

UK Registry Finds Long-Term Survival After TAVR Depends on Patient Characteristics

Early Data Show Novel Catheter-Implanted Device Benefits Patients with Left Heart Failure

DIRECT FLOW MEDICAL® TRANSCATHETER AORTIC VALVE SYSTEM DEMONSTRATES EXCELLENT 12 MONTH OUTCOMES IN DISCOVER CE MARK TRIAL

DIRECT FLOW MEDICAL, INC. ANNOUNCES IDE APPROVAL FOR U.S. PIVOTAL TRIAL

Boston Scientific Lotus™ Valve System Demonstrates Strong Performance And Safety Profile At Six Months

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content